OSELTAMIVIR PHOSPHATE
Generic: OSELTAMIVIR PHOSPHATE
Zydus Lifesciences LimitedManufacturer
ORALRoute
OSELTAMIVIR PHOSPHATEActive Substance
2017-02-24Original Approval
OSELTAMIVIR PHOSPHATE is FDA application ANDA208578, sponsored by ZYDUS PHARMS. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class II2024-02-13
Oseltamivir Phosphate for Oral Suspension 6mg/ml, 60 mL (reconstituted) bottle, RX only, Distributed by Amneal PharmaceuFailed Impurities/Degradation Specifications: Out-of-specification test results.
Class III2021-01-21
Oseltamivir Phosphate for Oral Suspension, 6 mg/mL, 60 mL (usable volume after constitution), Rx only, Manufactured for:Failed Impurities/Degradation Specifications; Out-of-specification test results observed for Impurit
Class II2021-03-15
Oseltamivir Phosphate for Oral Suspension 6 mg/mL* *Each mL contains 6 mg oseltamivir base after constitution. 60 mL (uCGMP Deviations: Intermittent exposure to temperature excursion during storage.
Top Reported Reactions
1
OFF LABEL USE
1,906 reports
2
DRUG INEFFECTIVE
829 reports
3
NO ADVERSE EVENT
585 reports
4
VOMITING
505 reports
5
NAUSEA
499 reports
6
HEADACHE
462 reports
7
DRUG INTOLERANCE
438 reports
8
PNEUMONIA
407 reports
9
CONDITION AGGRAVATED
399 reports
10
PRODUCT USE IN UNAPPROVED INDICATION
360 reports